← Back to Patent Explorer
US5073373A Expired / Lapsed US ⏱️ 0.0 years remaining

Flowable demineralized bone powder composition and its use in bone repair

Assignee: Osteotech Investment Corp
•
Filing: 1989-09-21
•
Granted: 1991-12-17
•
Expires: 2009-09-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A flowable demineralized bone powder composition is provided for use in surgical bone repair.

Inventors

  • 👤 Robert K. O'Leary
  • 👤 Patrick A. McBrayer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:27
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/36; A61L27/3604; A61L27/3608; A61K; A61K35/00; A61K35/12; A61K35/32; A61L24/00; A61L24/0005; A61L27/14; A61L27/22; A61L27/227; A61L27/3641; A61L27/3645; A61L27/365; A61F; A61F2/00; A61F2/02; A61F2/28; A61F2002/2835; A61L2400/00; A61L2400/06; A61L2430/00; A61L2430/02

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 55 words
A flowable composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth-inducing amount of pulverized demineralized osteogenic bone powder in a biocompatible carrier for the bone powder wherein said carrier is selected from the group consisting of glycerol, monoacetin, diacetin and mixtures thereof.
Claim 2
Dependent Claim 55 words
A flowable composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth-inducing amount of pulverized demineralized osteogenic bone powder in a biocompatible carrier for the bone powder wherein said carrier is selected from the group consisting of glycerol, monoacetin, diacetin and mixtures thereof.
Claim 3
Dependent Claim 23 words
The composition of claim 1 wherein the average particle size of the demineralized bone powder is from about 0.1 to about 1.2 cm.
Claim 4
Dependent Claim 10 words
The composition of claim 1 wherein the carrier is glycerol.
Claim 5
Dependent Claim 72 words
The composition of claim 3 containing at least one additional ingredient selected from the group consisting of antiviral agent, antimicrobial agent, antibiotic agent, amino acid, peptide, vitamin, protein synthesis co-factor hormone, endocrine tissue, synthesizer, enzyme, polymer-cell scaffolding agent with parenchymal cells, angiogenic drug, polymeric drug carrier, collagen lattice, antigenic agent, cytoskeletal agent, mesenchymal agent, bone digester, antitumor agent, cellular attractant, cellular attachment agent, immunosuppressant, nucleic acid, surface active agent and penetration enhancer.
Claim 6
Dependent Claim 23 words
The composition of claim 1 wherein the average particle size of the demineralized bone powder is from about 0.2 to about 1 cm.
Claim 7
Dependent Claim 21 words
The composition of claim 1 wherein the demineralized bone powder is derived from cortical bone, cancellous and/or corticocancellous allogenic bone tissue.
Claim 8
Dependent Claim 17 words
The composition of claim 1 containing from about 5 to about 80 weight percent demineralized bone powder.
Claim 9
Dependent Claim 17 words
The composition of claim 1 containing from about 20 to about 60 weight percent demineralized bone powder.
Claim 10
Dependent Claim 72 words
The composition of claim 1 containing at least one additional ingredient selected from the group consisting of antiviral agent, antimicrobial agent, antibiotic agent, amino acid, peptide, vitamin, protein synthesis co-factor, hormone, endocrine tissue, synthesizer, enzyme, polymer-cell scaffolding agent with parenchymal cells, angiogenic drug, polymeric drug carrier, collagen lattice, antigenic agent, cytoskeletal agent, mesenchymal agent, bone digester, antitumor agent, cellular attractant, cellular attachment agent, immunosuppressant, nucleic acid, surface active agent and penetration enhancer.
Claim 11
Dependent Claim 23 words
The composition of claim 3 wherein the average particle size of the demineralized bone powder is from about 0.1 to about 1.2 cm.
Claim 12
Dependent Claim 23 words
The composition of claim 3 wherein the average particle size of the demineralized bone powder is from about 0.2 to about 1 cm.
Claim 13
Dependent Claim 20 words
The composition of claim 3 wherein the demineralized bone powder is derived from cortical cancellous and/or corticocancellous allogenic bone tissue.
Claim 14
Dependent Claim 17 words
The composition of claim 3 containing from about 5 to about 80 weight percent demineralized bone powder.
Claim 15
Dependent Claim 17 words
The composition of claim 3 containing from about 20 to about 60 weight percent demineralized bone powder.

References Cited (Backward Citations)

US3458397A Cited
SU880425A1 Cited
EP0082621A1 Cited
US4440750A Cited
US4458733A Cited
US4563489A Cited
US4595713A Cited
GB2175807A Cited
WO1986007265A1 Cited
WO1989004646A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-12-16 1995-06-17 1995-12-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-12-16 1999-06-17 1999-12-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-12-16 2003-06-17 2003-12-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag